Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Sanofi teams with virtual reality biotech on oral Dupixent successor
Sanofi teams with virtual reality biotech on oral Dupixent successor
Endpoints
Sanofi
Dupixent
C4X Discovery
small molecule drugs
Flag link:
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Dupixent
Regeneron
Sanofi
eczema
Flag link:
Pfizer, still chasing Dupixent, releases fifth round of data for eczema JAK inhibitor abrocitinib
Pfizer, still chasing Dupixent, releases fifth round of data for eczema JAK inhibitor abrocitinib
Endpoints
Pfizer
JAK inhibitors
abrocitinib
Dupixent
atopic dermatitis
clinical trials
Flag link:
Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp
Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp
Fierce Pharma
Sanofi
earnings
Dupixent
Paul Hudson
Pharma CEOs
Flag link:
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Fierce Pharma
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Flag link:
Dupixent Posts Positive Results in Phase III Pediatric Asthma Study
Dupixent Posts Positive Results in Phase III Pediatric Asthma Study
BioSpace
Regeneron
Sanofi
pediatric
asthma
clinical trials
Dupixent
Flag link:
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
Flag link:
Can Sanofi's top drug carry it through a pandemic?
Can Sanofi's top drug carry it through a pandemic?
BioPharma Dive
Sanofi
Dupixent
earnings
pandemic
COVID-19
Flag link:
Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA
Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA
Endpoints
LEO Pharma
psoriasis
Sanofi
Dupixent
LP0058
Flag link:
LEO eyeing 2021 US launch for eczema drug tralokinumab
LEO eyeing 2021 US launch for eczema drug tralokinumab
Pharmaforum
LEO Pharma
eczema
tralokinumab
Sanofi
Dupixent
Flag link:
Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug
Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug
Yahoo/SmarterAnalyst
Sanofi
Regeneron
China
Dupixent
atopic dermatitis
Flag link:
New safety data expose potential weakness as Pfizer's abrocitinib takes on Dupixent in eczema
New safety data expose potential weakness as Pfizer's abrocitinib takes on Dupixent in eczema
Endpoints
Pfizer
abrocitinib
Dupixent
clinical trials
eczema
Flag link:
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
BioSpace
Sanofi
Regeneron
Dupixent
atopic dermatitis
pediatric
Flag link:
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Dupixent
Sanofi
Regeneron
esosinophilic esophagitis
EoE
clinical trials
Flag link:
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?
Motley Fool
Regeneron
Eylea
Dupixent
Flag link:
Aslan's Dupixent rival test put on hold amid COVID-19, but delays shouldn't hit readout
Aslan's Dupixent rival test put on hold amid COVID-19, but delays shouldn't hit readout
Fierce Biotech
Aslan Pharma
ASLAN004
Regeneron
Sanofi
Dupixent
atopic dermatitis
Flag link:
Sanofi and Regeneron's Dupixent shows more encouraging results
Sanofi and Regeneron's Dupixent shows more encouraging results
Reuters
Sanofi
Dupixent
atopic dermatitis
clinical trials
Flag link:
Will Eczema Drug Dupixent Transform Sanofi?
Will Eczema Drug Dupixent Transform Sanofi?
Motley Fool
Sanofi
Dupixent
Paul Hudson
Flag link:
Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema
Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema
Pharmaforum
Sanofi
Dupixent
NHS
Wales
Scotland
atopic dermatitis
Flag link:
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Flag link:
Pages
1
2
3
4
next ›
last »